BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18782076)

  • 1. Clinical trials of targeted alpha therapy for cancer.
    Allen BJ
    Rev Recent Clin Trials; 2008 Sep; 3(3):185-91. PubMed ID: 18782076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted alpha therapy for cancer.
    Allen BJ; Raja C; Rizvi S; Li Y; Tsui W; Zhang D; Song E; Qu CF; Kearsley J; Graham P; Thompson J
    Phys Med Biol; 2004 Aug; 49(16):3703-12. PubMed ID: 15446799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic targeted alpha radiotherapy for cancer.
    Allen B
    J Biomed Phys Eng; 2013 Sep; 3(3):67-80. PubMed ID: 25505750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancer.
    Allen BJ; Raja C; Rizvi S; Song EY; Graham P
    Phys Med Biol; 2007 Jul; 52(13):L15-9. PubMed ID: 17664565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review.
    ; Parker C; Lewington V; Shore N; Kratochwil C; Levy M; Lindén O; Noordzij W; Park J; Saad F
    JAMA Oncol; 2018 Dec; 4(12):1765-1772. PubMed ID: 30326033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trials.
    Marcu L; Bezak E; Allen BJ
    Crit Rev Oncol Hematol; 2018 Mar; 123():7-20. PubMed ID: 29482781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovation, Impact, and Strategic Importance of Alpha-Emitting Radionuclides.
    Mirzadeh S
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S21-S25. PubMed ID: 31420270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Appendix of Radionuclides Used in Targeted Alpha Therapy.
    Ferrier MG; Radchenko V
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S58-S65. PubMed ID: 31427258
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and preclinical targeted alpha therapy for melanoma, breast, prostate and colorectal cancers.
    Allen BJ; Rizvi S; Li Y; Tian Z; Ranson M
    Crit Rev Oncol Hematol; 2001; 39(1-2):139-46. PubMed ID: 11418311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancements in cancer therapy with alpha-emitters: a review.
    Imam SK
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):271-8. PubMed ID: 11516878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted α-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies.
    Jadvar H
    Cancer Biother Radiopharm; 2020 Sep; 35(7):475-484. PubMed ID: 32202923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted α-Therapy.
    Brechbiel MW
    Cancer Biother Radiopharm; 2020 Aug; 35(6):397. PubMed ID: 32503377
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeted Radiotherapy with Alpha-Particle Emitting Radionuclides Seminar, November 18, 2004, Cracow, Poland.
    Zalutsky MR; Petelenz B
    Nucl Med Rev Cent East Eur; 2004; 7(2):195. PubMed ID: 15968616
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of Targeted Alpha Therapy from Bench to Bedside.
    Morgenstern A; Bruchertseifer F
    J Med Imaging Radiat Sci; 2019 Dec; 50(4S1):S18-S20. PubMed ID: 31405818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy with α-particle-emitting radionuclides.
    Seidl C
    Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Targeted Alpha Particle Therapy for Solid Tumors.
    Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
    Bruland ØS; Nilsson S; Fisher DR; Larsen RH
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6250s-6257s. PubMed ID: 17062709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.
    Morgenstern A; Bruchertseifer F; Apostolidis C
    Curr Radiopharm; 2012 Jul; 5(3):221-7. PubMed ID: 22642390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.